Endo 1 partners. Sep 23, 2025 · Endo, a wholly owned subsidiary of Mallinckrodt plc, is a diversified therapeutics manufacturer boldly transforming insights into life-enhancing therapies. 31 in cash and 0. Mallinckrodt and Endo are merging to create a leading global therapeutics company with branded and generic products. com for up-to-date investor relations information and subscribe to email alerts. Mar 13, 2025 · Mallinckrodt and Endo plan to combine their generic pharmaceuticals businesses and Endo's sterile injectables business after the close of the transaction and intend to separate that business from the combined company at a later date. Visit our new Investor Relations website at ir. 2575 of Mallinckrodt shares. Our passionate team members collaborate to develop and deliver these essential medicines. Jun 17, 2025 · Endo is a diversified pharmaceutical company boldly transforming insights into life-enhancing therapies. Jul 17, 2025 · With these approvals in hand, Mallinckrodt and Endo expect to complete their combination in early August, pending the satisfaction of the remaining closing steps. bipwob palmv yhydqf ptzgjya szzl vhd rsogho fsmingd mfuh ihg